We are a clinical-stage biotechnology company pioneering
the development of lentivirus-based first-in-class gene and cell therapies in cancer.
At Genenta, we use gene-based cytokine delivery to activate the immune system within the tumor,
providing a controlled, targeted and enduring anti-tumor response.
the development of lentivirus-based first-in-class gene and cell therapies in cancer.
At Genenta, we use gene-based cytokine delivery to activate the immune system within the tumor,
providing a controlled, targeted and enduring anti-tumor response.
